Headache & Migraine
Literature Review
‘Impressive’ results for intranasal ketamine in chronic, refractory migraine
“If anything works, even partially and shortly, it may still give patients some relief to get through the day.”
Conference Coverage
Head-to-head comparison of migraine meds reveals top options
“To the best of our knowledge, this is the first study that simultaneously compared multiple acute migraine medications using a Big Data analysis...
FDA/CDC
FDA expands atogepant approval to include chronic migraine
The approval makes atogepant the first, and only, oral CGRP receptor antagonist approved to prevent migraine across frequencies, including...
Conference Coverage
Atogepant prevents episodic migraine in some difficult-to-treat cases
Initial results showed patients receiving oral atogepant had significantly fewer mean monthly migraine days, achieved 50% or greater reduction in...
Literature Review
Cluster, migraine headache strongly linked to circadian rhythm
“These findings help us explain the timing to patients – for example, it is possible that a headache at 8 a.m. is due to their internal body clock...
30th Anniversary
Headache before the revolution: A clinician looks back
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
From the Journals
Migraine after concussion linked to worse outcomes
Although most children recover quickly from a concussion, approximately one-third continue to report symptoms a month after the event.
Literature Review
‘Quick, affordable’ test helps predict CGRP response for migraine
Pretreatment nonictal cephalic allodynia identified galcanezumab responders with nearly 80% accuracy.
Feature
How a concussion led a former football player/WWE star to a pioneering neuroscience career
The NIH and the CDC are now in agreement about the risks of participating in impact sports and activities.
From the Journals
Remote electrical neuromodulation device helps reduce migraine days
The device decreased the number of migraine days by an average of 4 days per month.
Literature Review
Dietary zinc seen reducing migraine risk
New evidence adds the mineral to a growing list of nutritional factors that can influence migraine.